Bnp Paribas Asset Management Holding S.A. Tg Therapeutics, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,357 shares of TGTX stock, worth $36,245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,357Holding current value
$36,245% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
415Shares Held
88.5MCall Options Held
2.34MPut Options Held
1.93M-
Vanguard Group Inc Valley Forge, PA15.6MShares$417 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$304 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$199 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$93.2 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$76 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.88B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...